JWS
INSY

Juncture Wealth Strategies’s Insys Therapeutics, Inc. INSY Stock Holding History

Juncture Wealth Strategies’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-12,847
Closed -$205K – 78
2016
Q1 		$205K Sell
12,847
-4,365
-25% -$82.9K 0.15% 75
2015
Q4 		$493K Sell
17,212
-1,290
-7% -$35.7K 0.37% 60
2015
Q3 		$527K Sell
18,502
-4,370
-19% -$161K 0.43% 58
2015
Q2 		$822K Sell
22,872
-5,406
-19% -$168K 0.67% 31
2015
Q1 		$822K Sell
28,278
-24,226
-46% -$641K 0.68% 36
2014
Q4 		$1.1M Buy
+52,504
New +$1.04M 0.53% 45

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Juncture Wealth Strategies's INSY Position: Q2 2016 in Review

Juncture Wealth Strategies sold out of Insys Therapeutics, Inc. (INSY) in Q2 2016, closing a stake of 12,847 shares — an estimated $205K sold.

Juncture Wealth Strategies first reported a position in INSY in Q4 2014 and held it in 6 quarters. The position peaked at $1.1M in Q4 2014. 124 funds tracked by Wall St. Rank hold INSY as of Q2 2016.

  • Juncture Wealth Strategies reported no remaining Insys Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
  • Juncture Wealth Strategies sold 12,847 Insys Therapeutics, Inc. shares in Q2 2016, an estimated $205K.
  • Juncture Wealth Strategies first reported a position in Insys Therapeutics, Inc. in Q4 2014 and held it in 6 quarters.
  • Juncture Wealth Strategies's Insys Therapeutics, Inc. position peaked at $1.1M in Q4 2014.
  • 124 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2016.

Based on Juncture Wealth Strategies's 13F filing for Q2 2016, filed 14 Jul 2016.